March 14, 2023 02:19 PM EDT

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week

Zachary Brennan

Senior Editor

Ahead of Thursday’s meeting of the FDA’s Antimicrobial Drugs Advisory Committee, which will decide whether to flip Pfizer’s blockbuster Covid-19 pill from an EUA to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Ahead of ad­comm for full ap­proval, FDA es­ti­mates Pfiz­er's Covid pill could save 1,500 lives per week

Senior Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week